Medical Condition News

RSS

Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.

30 Oct 2026

New FAIR Health platform maps chronic disease prevalence across the United States

Today, FAIR Health launches FAIR Health Atlas, a free epidemiological reporting platform incorporating data on the commercially insured population.

30 Oct 2026

Norrin treatment prevents vision loss in diabetic rats

Over 100 million people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes.

30 Oct 2026

Researchers test noninvasive ultrasound treatment for schizophrenia-related hallucinations

Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations.

30 Oct 2026

FDA approves ILUMYA for adults with active psoriatic arthritis

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

30 Oct 2026

Physiological signals help AI predict post-concussion headaches and fatigue

Some people who suffer a concussion struggle with headaches and fatigue afterwards. Headaches and fatigue follow a consistent pattern that could potentially be used to warn the patient a full day before the symptoms set in.

30 Oct 2026

Space-grown organoids better replicate aggressive glioblastoma tumors

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and deadly forms of cancer.

30 Oct 2026

Immunotherapy reshapes immune cell interactions in melanoma-affected lymph nodes

A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after melanoma has spread to them.

30 Oct 2026

Myeloid immune cells play key roles in aortic health and disease

The aorta is often viewed primarily as the body's largest blood vessel-a durable conduit that delivers oxygen-rich blood from the heart to every organ.

30 Oct 2026

Hyperactive cancer-promoting proteins help tumor cells evade immune attack

The immune system may recognize a cancer cell and still fail to destroy it. Researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.

30 Oct 2026

Incisionless brain procedure eliminates Parkinson's tremors for air force veteran

To the untrained eye, a "ham" radio may look like a simple device. However, inside its casing, dozens of delicate wires and tiny elements perform distinct yet connected functions to deliver messages to a vast network of operators around the world.

30 Oct 2026

Mayo Clinic enters new medical era with precure research

Mayo Clinic researchers are uncovering the earliest shifts in disease biology - long before symptoms appear - revealing how disease takes root and opening new possibilities to identify, predict and potentially prevent disease before symptoms develop.

30 Oct 2026

Targeting specific enzyme reverses radiation-induced immune suppression in cancer

Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

30 Oct 2026

Targeting ANO6 protein weakens pancreatic cancer and boosts immunity

Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).

30 Oct 2026

Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects

A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for prostate cancer patients.

30 Oct 2026

Gut microbial catalog reveals systemic inflammation drivers in spinal injury

Scientists exploring the links between a spinal cord injury, inflammation and immune function have turned their attention to a genome-level analysis of the gut microbial community, with early study results offering hints at potential new approaches to aid healing.

30 Oct 2026

Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis

New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are cells involved in blood clotting. Platelets also communicate with other cells and can influence immune activity. The overactive platelets in people with glioblastoma slow the activity of cancer-fighting T cells, which can contribute to tumor growth and cancer progression.

30 Oct 2026

Online reviews reveal troubling side effects of insomnia drug lemborexant

Researchers from Rutgers and other universities analyzed hundreds of online reviews on lemborexant – and learned that about 1 in 4 of the reviewers stopped or planned to stop taking the prescription medication used to treat insomnia.

29 Oct 2026

Stem cell transplantation shows sustained benefits in severe systemic sclerosis

An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation, adding important evidence on sustained positive clinical outcomes and long-term safety in patients treated for early severe systemic sclerosis.

29 Oct 2026

Major studies identify accurate non-invasive tests for liver disease

Two major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, reducing reliance on liver biopsy.

29 Oct 2026

Medical Condition News

Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines

New FAIR Health platform maps chronic disease prevalence across the United States

Norrin treatment prevents vision loss in diabetic rats

Researchers test noninvasive ultrasound treatment for schizophrenia-related hallucinations

FDA approves ILUMYA for adults with active psoriatic arthritis

Physiological signals help AI predict post-concussion headaches and fatigue

Space-grown organoids better replicate aggressive glioblastoma tumors

Immunotherapy reshapes immune cell interactions in melanoma-affected lymph nodes

Myeloid immune cells play key roles in aortic health and disease

Hyperactive cancer-promoting proteins help tumor cells evade immune attack

Incisionless brain procedure eliminates Parkinson's tremors for air force veteran

Mayo Clinic enters new medical era with precure research

Targeting specific enzyme reverses radiation-induced immune suppression in cancer

Targeting ANO6 protein weakens pancreatic cancer and boosts immunity

Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects

Gut microbial catalog reveals systemic inflammation drivers in spinal injury

Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis

Online reviews reveal troubling side effects of insomnia drug lemborexant

Stem cell transplantation shows sustained benefits in severe systemic sclerosis

Major studies identify accurate non-invasive tests for liver disease

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News